Literature DB >> 19242375

Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.

Rachel Rosenthal1, Célia Groeper, Laura Bracci, Michel Adamina, Chantal Feder-Mengus, Paul Zajac, Giandomenica Iezzi, Martin Bolli, Walter P Weber, Daniel M Frey, Urs von Holzen, Daniel Oertli, Michael Heberer, Giulio C Spagnoli.   

Abstract

Common receptor gamma chain (c-gamma) cytokines (CKs) support proliferation of CD8+ T cells in presence or absence of antigen triggering and help maintaining the immunologic memory. We addressed the effects of low (< or = 5 ng/mL)-dose interleukin (IL)-2, IL-7, or IL-15 on human naive and memory antigen-specific CD8+ T cells. Peripheral blood CD8+ lymphocytes proliferated with decreasing efficiency in response to IL-15, IL-7, and IL-2. Of note, IL-15 preferentially promoted expansion of CD45RA/CD8+ T-cell memory subset. Accordingly, cytotoxic T lymphocytes specific for cytomegalovirus-derived antigens from seropositive donors proliferated in response to IL-15 and, to lesser extent to IL-7, but poorly to IL-2. CD8+ T cells were then pretreated with CK before antigen stimulation using, as read out, specific cytotoxic activity. After the pretreatment with IL-15, but not IL-2, previously experienced viral antigens induced vigorous cytotoxic responses. Minor effects of IL-7 were also detectable. In contrast, IL-2 best supported the cytotoxic T lymphocyte generation from prevailingly naive CD8 T cells from HLA-A*0201 healthy donors, specific for L27Melan-A/MART-126-35 melanoma-associated antigen. Cells from melanoma patients were tested before and after Melan-A/MART-1-targeted antigen-specific immunotherapy. Untreated patients showed heterogeneous patterns of responsiveness to c-gamma CK. However, when naive patients whose CD8+ T cells best responded to IL-2 were vaccinated, a modified responsiveness pattern was detectable. After immunization, cells displayed a significantly higher response to IL-15 than to IL-2 pretreatment. Thus, responsiveness to c-gamma CK is critically influenced by naive or memory status of peripheral blood CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242375     DOI: 10.1097/CJI.0b013e3181998e03

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  8 in total

1.  Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Authors:  Amanda Leone; Mukta Rohankhedkar; Afam Okoye; Alfred Legasse; Michael K Axthelm; Francois Villinger; Michael Piatak; Jeffrey D Lifson; Brigitte Assouline; Michel Morre; Louis J Picker; Donald L Sodora
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

Review 2.  Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Authors:  Vasudha Sundaravaradan; Kiran D Mir; Donald L Sodora
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

3.  IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion.

Authors:  Kevin C Conlon; E Lake Potter; Stefania Pittaluga; Chyi-Chia Richard Lee; Milos D Miljkovic; Thomas A Fleisher; Sigrid Dubois; Bonita R Bryant; Michael Petrus; Liyanage P Perera; Jennifer Hsu; William D Figg; Cody J Peer; Joanna H Shih; Jason L Yovandich; Stephen P Creekmore; Mario Roederer; Thomas A Waldmann
Journal:  Clin Cancer Res       Date:  2019-05-29       Impact factor: 12.531

4.  Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells.

Authors:  Inge Jedema; Marian van de Meent; Jeanette Pots; Michel G D Kester; Martha T van der Beek; J H Frederik Falkenburg
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

5.  Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates.

Authors:  Enrico Lugli; Carolyn K Goldman; Liyanage P Perera; Jeremy Smedley; Rhonda Pung; Jason L Yovandich; Stephen P Creekmore; Thomas A Waldmann; Mario Roederer
Journal:  Blood       Date:  2010-07-14       Impact factor: 22.113

6.  Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.

Authors:  Chantal Mengus; Clémentine Le Magnen; Emanuele Trella; Kawa Yousef; Lukas Bubendorf; Maurizio Provenzano; Alexander Bachmann; Michael Heberer; Giulio C Spagnoli; Stephen Wyler
Journal:  J Transl Med       Date:  2011-09-26       Impact factor: 5.531

7.  Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression.

Authors:  Kunyu Li; Margaret Baird; Jianping Yang; Chris Jackson; Franca Ronchese; Sarah Young
Journal:  Clin Transl Immunology       Date:  2016-08-12

8.  Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.

Authors:  H B Deepak; Sabina Evan Prince; Pratima Deshpande
Journal:  Indian J Pharmacol       Date:  2022 May-Jun       Impact factor: 2.833

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.